原发性胆汁性胆管炎患者44年间疾病分期趋轻:自然史正在改变
该研究纳入1970至2014年间欧洲和北美17个中心的4805例原发性胆汁性胆管炎患者,按诊断年代分为5组,比较诊断年龄、疾病分期、熊去氧胆酸应答和临床结局。结果显示诊断年龄每十年增加2-3岁,轻度生化及组织学分期比例上升,熊去氧胆酸应答率提高,失代偿率下降,10年无移植生存率提高。
要点
- 诊断年龄从1970年代的46.9±10.1岁增至2010年后的57.0±12.1岁(P < 0.001)。
- 轻度生化疾病比例从1970年代的41.3%升至1990年代的72.2%(P < 0.001)。
- 10年无移植生存率从48.4%升至80.1%(各年代队列,P < 0.001)。
核心结论
- 近几十年来原发性胆汁性胆管炎呈现诊断年龄更大且疾病严重度降低的趋势,可能由常规肝功能检测增加和/或环境触发因素改变解释。
研究设计与样本
- 国际多中心队列研究,纳入1970至2014年间欧洲和北美17个中心的4805例原发性胆汁性胆管炎患者。
- 按诊断年代分为5组:1970-1979年(n = 143)、1980-1989年(n = 858)、1990-1999年(n = 1,754)、2000-2009年(n = 1,815)、≥2010年(n = 235)。
主要发现
- 平均诊断年龄从1970年代的46.9 ± 10.1岁增至2010年后的57.0 ± 12.1岁,每十年增加2-3岁(P < 0.001)。
- 女性与男性比例(9:1)和抗线粒体抗体阳性率(90%)无显著变化。
- 轻度生化疾病(根据Rotterdam分期)比例从1970年代的41.3%升至1990年代的72.2%(P < 0.001),此后相对稳定。
- 诊断时轻度组织学分期患者比例从60.4%(1970-1989年)升至76.5%(1990-2014年)(P < 0.001)。
- 根据Paris-I标准的熊去氧胆酸应答率从1970年代的51.7%升至1990年代的70.5%(P < 0.001);失代偿率从1970年代的18.5%降至2000年代的5.8%(P < 0.001);10年无移植生存率各年代队列分别为48.4%、68.7%、79.7%和80.1%(P < 0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Changes over time in the presenting features and clinical course of patients with primary biliary cholangitis are poorly described. We sought to describe temporal trends in patient and disease characteristics over a 44-year period across a large international primary biliary cholangitis cohort of 4,805 patients diagnosed between 1970 and 2014, from 17 centers across Europe and North America. Patients were divided into five cohorts according to their year of diagnosis: 1970-1979 (n = 143), 1980-1989 (n = 858), 1990-1999 (n = 1,754), 2000-2009 (n = 1,815), and ≥2010 (n = 235). Age at diagnosis, disease stage, response to ursodeoxycholic acid, and clinical outcomes were compared. Mean age at diagnosis increased incrementally by 2-3 years per decade from 46.9 ± 10.1 years in the 1970s to 57.0 ± 12.1 years from 2010 onward (P < 0.001). The female to male ratio (9:1) and antimitochondrial antibody positivity (90%) were not significantly variable. The proportion of patients presenting with mild biochemical disease (according to Rotterdam staging) increased from 41.3% in the 1970s to 72.2% in the 1990s (P < 0.001) and remained relatively stable thereafter. Patients with a mild histological stage at diagnosis increased from 60.4% (1970-1989) to 76.5% (1990-2014) (P < 0.001). Correspondingly, response to ursodeoxycholic acid according to Paris-I criteria increased; 51.7% in the 1970s and 70.5% in the 1990s (P < 0.001). Recent decades were also characterized by lower decompensation rates (18.5% in the 1970s to 5.8% in the 2000s, P < 0.001) and higher 10-year transplant-free survival (48.4%, 68.7%, 79.7%, and 80.1% for each respective cohort; P < 0.001). CONCLUSION: In recent decades, a pattern of primary biliary cholangitis presentation consistent with an older age at diagnosis alongside reduced disease severity has been noted; the observed trends may be explained by an increase in routine testing of liver function and/or a changing environmental trigger. (Hepatology 2018;67:1920-1930).
引用
- Murillo Perez CF, Goet JC, Lammers WJ, et al. Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history. Hepatology. 2018. PMID: 29220537. doi:10.1002/hep.29717
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。